205 related articles for article (PubMed ID: 11441423)
1. Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.
Nann-Vernotica E; Donny EC; Bigelow GE; Walsh SL
Psychopharmacology (Berl); 2001 Jun; 155(4):338-47. PubMed ID: 11441423
[TBL] [Abstract][Full Text] [Related]
2. Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans.
Haney M; Ward AS; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2001 Jun; 155(4):330-7. PubMed ID: 11441422
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166).
Romach MK; Glue P; Kampman K; Kaplan HL; Somer GR; Poole S; Clarke L; Coffin V; Cornish J; O'Brien CP; Sellers EM
Arch Gen Psychiatry; 1999 Dec; 56(12):1101-6. PubMed ID: 10591286
[TBL] [Abstract][Full Text] [Related]
4. Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).
Chausmer AL; Smith BJ; Kelly RY; Griffiths RR
Behav Pharmacol; 2003 Mar; 14(2):111-20. PubMed ID: 12658071
[TBL] [Abstract][Full Text] [Related]
5. Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists.
Tella SR
Pharmacol Biochem Behav; 1994 May; 48(1):151-9. PubMed ID: 8029285
[TBL] [Abstract][Full Text] [Related]
6. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans.
Walsh SL; Geter-Douglas B; Strain EC; Bigelow GE
J Pharmacol Exp Ther; 2001 Oct; 299(1):147-58. PubMed ID: 11561074
[TBL] [Abstract][Full Text] [Related]
7. Locomotor and discriminative-stimulus effects of cocaine in dopamine D5 receptor knockout mice.
Elliot EE; Sibley DR; Katz JL
Psychopharmacology (Berl); 2003 Sep; 169(2):161-8. PubMed ID: 12768268
[TBL] [Abstract][Full Text] [Related]
8. Maintained cocaine self-administration is determined by quantal responses: implications for the measurement of antagonist potency.
Norman AB; Tabet MR; Norman MK; Tsibulsky VL
J Pharmacol Exp Ther; 2014 Feb; 348(2):311-5. PubMed ID: 24307200
[TBL] [Abstract][Full Text] [Related]
9. Effects of isradipine on cocaine-induced subjective mood.
Johnson BA; Roache JD; Ait-Daoud N; Wells LT; Mauldin JB
J Clin Psychopharmacol; 2004 Apr; 24(2):180-91. PubMed ID: 15206666
[TBL] [Abstract][Full Text] [Related]
10. A clinical trial of safety and tolerability for the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease.
Khasnavis T; Reiner G; Sommerfeld B; Nyhan WL; Chipkin R; Jinnah HA
Mol Genet Metab; 2016 Apr; 117(4):401-6. PubMed ID: 26922636
[TBL] [Abstract][Full Text] [Related]
11. Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists.
Reeves R; Thiruchelvam M; Cory-Slechta DA
Brain Res; 2004 May; 1008(2):155-67. PubMed ID: 15145752
[TBL] [Abstract][Full Text] [Related]
12. Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion.
Neisewander JL; Fuchs RA; O'Dell LE; Khroyan TV
Synapse; 1998 Oct; 30(2):194-204. PubMed ID: 9723789
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.
Comer SD; Mogali S; Saccone PA; Askalsky P; Martinez D; Walker EA; Jones JD; Vosburg SK; Cooper ZD; Roux P; Sullivan MA; Manubay JM; Rubin E; Pines A; Berkower EL; Haney M; Foltin RW
Neuropsychopharmacology; 2013 Nov; 38(12):2427-38. PubMed ID: 23736314
[TBL] [Abstract][Full Text] [Related]
14. Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking.
Johnson BA; Roache JD; Ait-Daoud N; Gunderson EW; Haughey HM; Wang XQ; Liu L
Addict Biol; 2013 May; 18(3):405-16. PubMed ID: 23039088
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates.
Khroyan TV; Platt DM; Rowlett JK; Spealman RD
Psychopharmacology (Berl); 2003 Jul; 168(1-2):124-131. PubMed ID: 12607074
[TBL] [Abstract][Full Text] [Related]
16. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat.
Caine SB; Heinrichs SC; Coffin VL; Koob GF
Brain Res; 1995 Sep; 692(1-2):47-56. PubMed ID: 8548319
[TBL] [Abstract][Full Text] [Related]
17. Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists.
Ciccocioppo R; Sanna PP; Weiss F
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1976-81. PubMed ID: 11172061
[TBL] [Abstract][Full Text] [Related]
18. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
19. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development.
Platt DM; Rowlett JK; Spealman RD
Psychopharmacology (Berl); 2002 Oct; 163(3-4):265-82. PubMed ID: 12373428
[TBL] [Abstract][Full Text] [Related]
20. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
Gilbert DL; Murphy TK; Jankovic J; Budman CL; Black KJ; Kurlan RM; Coffman KA; McCracken JT; Juncos J; Grant JE; Chipkin RE
Mov Disord; 2018 Aug; 33(8):1272-1280. PubMed ID: 30192018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
